Effect of the lantibiotic nisin on inhibitory and bactericidal activities of antibiotics used against vancomycin-resistant enterococci

Effect of the lantibiotic nisin on inhibitory and bactericidal activities of antibiotics used against vancomycin-resistant enterococci

Objectives: Antibiotic resistance is a serious issue facing clinicians all over the world. Vancomycin-resistant enterococci (VRE) are amongst the most common resistant pathogens that are isolated from patients suffering from infections in our locality. New antimicrobial agents such as the lantibioti...

Full description

Bibliographic Details
Main Authors:	Samah Sabry El-Kazzaz, Noha Tharwat Abou El-Khier
Format:	Article
Language:	English
Published:	Elsevier 2020-09-01
Series:	Journal of Global Antimicrobial Resistance
Subjects:	Lantibiotic Nisin Bactericidal Vancomycin-resistant enterococci
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213716520300606

Similar Items

Molecular Dynamics Insight into the Lipid II Recognition by Type A Lantibiotics: Nisin, Epidermin, and Gallidermin
by: Irina Panina, et al.
Published: (2021-09-01)

In vitro antagonistic effect of nisin on faecal enterococci and staphylococci
by: A. Lauková, et al.
Published: (2001-09-01)

Protein defence systems against the lantibiotic nisin: Function of the immunity protein NisI and the resistance protein NSR
by: Sakshi eKhosa, et al.
Published: (2016-04-01)

Discovery of the Potentiator of the Pore-Forming Ability of Lantibiotic Nisin: Perspectives for Anticancer Therapy
by: Dayana N. Chernyshova, et al.
Published: (2022-11-01)

Bioengineering lantibiotics for therapeutic success
by: Des eField, et al.
Published: (2015-11-01)

The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity
by: Liang eZhou, et al.
Published: (2015-01-01)

Vancomycin-resistant Enterococci: Epidemiology and Control
by: Yeşim ÇETİNKAYA
Published: (2000-03-01)

A modified method for the turbidimetric assay of nisin
by: Simone Hickmann Flôres, et al.
Published: (2003-06-01)

Specificity and Application of the Lantibiotic Protease NisP
by: Manuel Montalbán-López, et al.
Published: (2018-02-01)

Potentiating the activity of nisin against Escherichia coli
by: Liang eZhou, et al.
Published: (2016-02-01)

Enterococci, <i>Van</i> Gene-Carrying Enterococci, and Vancomycin Concentrations in the Influent of a Wastewater Treatment Plant in Southeast Germany
by: Michael Geissler, et al.
Published: (2024-01-01)

Insight into Two ABC Transporter Families Involved in Lantibiotic Resistance
by: Rebecca Clemens, et al.
Published: (2018-01-01)

Nisin E Is a Novel Nisin Variant Produced by Multiple <i>Streptococcus equinus</i> Strains
by: Ivan Sugrue, et al.
Published: (2023-02-01)

Identification of essential amino acid residues in the nisin dehydratase NisB
by: Rustem eKhusainov, et al.
Published: (2015-02-01)

Engineering of Nisin as a Means for Improvement of Its Pharmacological Properties: A Review
by: Mateusz Musiejuk, et al.
Published: (2023-07-01)

Our experiences with vancomycin-resistant enterococci in Jesenice General hospital
by: Helena Ribič, et al.
Published: (2007-11-01)

Design and Expression of Specific Hybrid Lantibiotics Active Against Pathogenic Clostridium spp.
by: Rubén Cebrián, et al.
Published: (2019-09-01)

In Silico Prediction and Analysis of Unusual Lantibiotic Resistance Operons in the Genus <i>Corynebacterium</i>
by: Oliver Goldbeck, et al.
Published: (2021-03-01)

Nisin S, a Novel Nisin Variant Produced by <i>Ligilactobacillus salivarius</i> P1CEA3
by: Ester Sevillano, et al.
Published: (2023-04-01)

Hospital-Acquired Vancomycin-Resistant Enterococci: A Report of 2 Year Experience
by: Seyed Morteza Taghavi, et al.
Published: (2009-12-01)

The N-terminal Region of Nisin Is Important for the BceAB-Type ABC Transporter NsrFP from Streptococcus agalactiae COH1
by: Jens Reiners, et al.
Published: (2017-08-01)

Hospital-Acquired Vancomycin-Resistant Enterococci: A Report of 2-year Ex-perience
by: Mehradad Hasibi, et al.
Published: (2009-12-01)

Prevalence of vancomycin-resistant Enterococci in India between 2000 and 2022: a systematic review and meta-analysis
by: Emily Smout, et al.
Published: (2023-08-01)

Risk factors for intestinal colonization with vancomycin resistant enterococci’ A prospective study in a level III pediatric intensive care unit
by: Rajesh Amberpet, et al.
Published: (2018-01-01)

Conjugation of Synthetic Polyproline Moietes to Lipid II Binding Fragments of Nisin Yields Active and Stable Antimicrobials
by: Jingjing Deng, et al.
Published: (2020-11-01)

Excretion of Vancomycin-Resistant Enterococci by Wild Mammals
by: David J. P. Mallon, et al.
Published: (2002-06-01)

Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a Brazilian teaching hospital
by: Antonia T. Tresoldi, et al.

Virulence markers of vancomycin resistant enterococci isolated from infected and colonized patients
by: Priyanka Paul Biswas, et al.
Published: (2014-01-01)

Nosocomial Infection with Vancomycin-dependent Enterococci
by: Paul A. Tambyah, et al.
Published: (2004-07-01)

Vancomycin-resistant Enterococci, Mexico City
by: Jennifer Cuellar-Rodríguez, et al.
Published: (2007-05-01)

Emergence of Vancomycin-Resistant Enterococci
by: Louis B. Rice
Published: (2001-04-01)

Minimum inhibitory concentration values and problematic disk break points of tigecycline against vancomycin and/or high-level aminoglycoside-resistant enterococci
by: Latife İşeri, et al.
Published: (2016-06-01)

Evaluation of Chromogenic Media in Detection of Vancomycin Resistant Enterococci
by: Vijaya D., et al.
Published: (2014-11-01)

Prevalence of Vancomycin-Resistant Enterococci and Antimicrobial Residues in Wastewater and Surface Water
by: Kristýna Hricová, et al.
Published: (2021-12-01)

Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients
by: Deivid William da Fonseca Batistão, et al.
Published: (2012-02-01)

Bio-Engineered Nisin with Increased Anti-<i>Staphylococcus </i>and Selectively Reduced Anti-<i>Lactococcus </i>Activity for Treatment of Bovine Mastitis
by: Des Field, et al.
Published: (2021-03-01)

Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance
by: Cornelius Remschmidt, et al.
Published: (2018-04-01)

The Surveyans of Colonisation of Vancomycin Resistant Enterococci and Investigation Antibiotic Susceptibility and Risk Factors
by: İrfan Binici, et al.
Published: (2022-04-01)

Vancomycin-resistant enterococci: an ongoing challenge for infection control
by: Andreas F.-X. Widmer
Published: (2012-05-01)

Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
by: Eric Mühlberg, et al.
Published: (2020-05-01)